Publications | Lund University Publications

1 – 4 of 4

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Hallek%2C+M%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Hallek%2C+M%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2024
Mark ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia^☆
Eichhorst, B. ; Ghia, P. ; Niemann, C. U. ; Kater, A. P. ; Gregor, M. ; Hallek, M. ; Jerkeman, M. ^LU and Buske, C. (2024) In Annals of Oncology 35(9). p.762-768
- Contribution to journal › Article
2023
Mark First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
Eichhorst, B. ; Juliusson, Gunnar ^LU and Hallek, M (2023) In New England Journal of Medicine 388(19). p.1739-1754
- Contribution to journal › Article
2017
Mark Targeting of B-cell receptor signalling in B-cell malignancies
Jerkeman, M. ^LU ; Hallek, M ; Dreyling, M ; Thieblemont, Catherine ; Kimby, E and Staudt, L. (2017) In Journal of Internal Medicine 282(5). p.415-428
- Contribution to journal › Scientific review
2015
Mark Total body irradiation after high-dose cytarabine in mantle cell lymphoma: A comparison of Nordic MCL2, HOVON-45, and European MCLYounger trials.
Hoster, E ; Geisler, C H ; Doorduijn, J ; van der Holt, B ; Walewski, J ; Bloehdorn, J ; Ribrag, V ; Salles, G ; Hallek, M and Pott, C , et al. (2015) In Leukemia
- Contribution to journal › Article

your query:: Remove author: Hallek, M